SightfileU.S. market data from official filings

UNITED THERAPEUTICS CORP (UTHR)

Name: UNITED THERAPEUTICS CORP (UTHR) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001082554 · EDGAR filings · Updated 2026-07-28

UNITED THERAPEUTICS CORP (UTHR) has reported institutional ownership of 97.8%, with 845 institutional managers holding positions valued at $24.6B per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership

97.8%

Institutional managers

845

Reported 13F value

$24.6B

Insider activity

1,294 trans.

−$710.5M net selling

Data flags

1 active

from SEC filings

Filings this week (20)

2026-07-28 — Insider transaction reported (Form 4)
2026-07-27 — Insider transaction reported (Form 4)
2026-07-27 — Insider transaction reported (Form 4)
2026-07-24 — Insider transaction reported (Form 4)
2026-07-23 — Insider transaction reported (Form 4)
2026-07-23 — Initial insider ownership filed (Form 3)
2026-07-23 — Insider transaction reported (Form 4)
2026-07-23 — Insider transaction reported (Form 4)
2026-07-23 — Insider transaction reported (Form 4)
2026-07-23 — Insider transaction reported (Form 4)
2026-07-23 — Insider transaction reported (Form 4)
2026-07-23 — Insider transaction reported (Form 4)
… and 8 more filings this week

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

2026-07-21 — Insider transaction reported (Form 4)
2026-07-20 — Insider transaction reported (Form 4)
2026-07-17 — Insider transaction reported (Form 4)
2026-07-16 — Insider transaction reported (Form 4)
2026-07-16 — Insider transaction reported (Form 4)
2026-07-16 — Notice of proposed sale filed (Form 144)
2026-07-15 — Insider transaction reported (Form 4)
2026-07-14 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, UNITED THERAPEUTICS CORP has 845 institutional holders and institutional ownership of 97.8%.

#	Institution	Reported value	% of tracked total
1	BlackRock, Inc.	$3.20B	13.0%
2	Avoro Capital Advisors LLC	$1.56B	6.3%
3	WELLINGTON MANAGEMENT GROUP LLP	$1.34B	5.5%
4	VANGUARD PORTFOLIO MANAGEMENT LLC	$1.19B	4.8%
5	VANGUARD CAPITAL MANAGEMENT LLC	$1.16B	4.7%
6	STATE STREET CORP	$1.09B	4.5%
7	RENAISSANCE TECHNOLOGIES LLC	$1.06B	4.3%
8	GEODE CAPITAL MANAGEMENT, LLC	$729.9M	3.0%
9	JANUS HENDERSON GROUP PLC	$514.0M	2.1%
10	AQR CAPITAL MANAGEMENT LLC	$486.4M	2.0%

Full holder history and quarter-over-quarter changes are available inside the app.

Insider activity

Insiders reported 1,294 transactions (0 buys, 1056 sells) across 14 reporting insiders, with a net reported value of −$710.5M.

Quarterly net insider value, as reported in Form 4 filings.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2021-05-05 (recurring since 2020-02-26) — source filing. The authoritative details are those stated in the filing itself.

Fails-to-deliver

The SEC's fails-to-deliver file for 2026-06-30 reports 3,068 failed-to-deliver shares ($459.9K) for UTHR — an official data point published by the SEC, shown as reported.

Related companies

NATERA INC (NTRA) · METTLER TOLEDO INTERNATIONAL (MTD) · BIOGEN INC (BIIB) · DEXCOM INC (DXCM) · NOVARTIS AG (NVS) · RESMED INC (RMD)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.